Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
Advertise
About Us
Pharma
Vaccines
Asia
Cell & Gene Therapy
Drug Delivery
Executives
Manufacturing
Facilities
Recalls
Warning Letters
Marketing
Special Reports
Fierce 50
Special Report
Awards Gala
Resources
Podcasts
Fierce Events
Industry Events
Webinars
Whitepapers
Survey
Events
Subscribe
Subscribe
Pharma
Vaccines
Asia
Cell & Gene Therapy
Drug Delivery
Executives
Manufacturing
Facilities
Recalls
Warning Letters
Marketing
Special Reports
Fierce 50
Special Report
Awards Gala
Resources
Podcasts
Fierce Events
Industry Events
Webinars
Whitepapers
Survey
Events
Subscribe
Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
Advertise
About Us
IQVIA
Marketing
IQVIA, DeepIntent abandon merger amid FTC scrutiny
The attempted merger between IQVIA and pharma ad specialist DeepIntent has been put on ice after continued scrutiny from the U.S. government.
Ben Adams
Jan 5, 2024 10:54am
IQVIA hit by decision to uphold block of its DeepIntent buyout
Dec 30, 2023 1:00pm
GSK-funded report on adult vaccine rates shows major declines
Jul 19, 2023 2:59pm
Feds sue IQVIA in effort to block digital pharma ads deal
Jul 18, 2023 9:15am
FTC targets digital pharma ads
May 11, 2023 10:45am
Carvykti, Sanofi, BeiGene—Fierce Pharma Asia
Feb 3, 2023 8:25am